FCFS

154.45

-3.47%↓

RPT.US

2.47

-0.8%↓

FCFS

154.45

-3.47%↓

RPT.US

2.47

-0.8%↓

FCFS

154.45

-3.47%↓

RPT.US

2.47

-0.8%↓

FCFS

154.45

-3.47%↓

RPT.US

2.47

-0.8%↓

FCFS

154.45

-3.47%↓

RPT.US

2.47

-0.8%↓

Search

Hannover Rueck SE

Open

SectorFinanciën

254.6 -0.7

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

249.2

Max

257.8

Belangrijke statistieken

By Trading Economics

Inkomsten

353M

834M

Verkoop

-950M

6.9B

K/W

Sectorgemiddelde

12.507

31.165

EPS

5.4

Dividendrendement

2.72

Winstmarge

12.052

Werknemers

4,013

EBITDA

323M

1.1B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+13.61% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.72%

3.89%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-989M

31B

Vorige openingsprijs

255.3

Vorige sluitingsprijs

254.6

Nieuwssentiment

By Acuity

41%

59%

176 / 528 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Hannover Rueck SE Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 nov 2025, 07:17 UTC

Winsten

Hannover Re Lifts Profit View

10 nov 2025, 08:27 UTC

Marktinformatie
Winsten

Hannover Re's Guidance Upgrade Pleases -- Market Talk

10 nov 2025, 06:48 UTC

Winsten

Hannover Re 2025 Target Return on Investments Under Own Management Revised to Around 2.9% vs. At Least 3.2%

10 nov 2025, 06:48 UTC

Winsten

Hannover Re Sees 2025 L&H Net CSM Growth Around 2%

10 nov 2025, 06:47 UTC

Winsten

Hannover Re Sees 2025 L&H Net Reinsurance Service Result More Than EUR875M

10 nov 2025, 06:46 UTC

Winsten

Hannover Re 2025 P&C Combined Ratio Now Seen Less Than 87%

10 nov 2025, 06:46 UTC

Winsten

Hannover Re 2025 P&C Gross Reinsurance Rev Growth More Than 7%

10 nov 2025, 06:45 UTC

Winsten

Hannover Re 2025 Earnings View Based on Large Loss Expenditure Not Significantly Exceeding EUR2.1B

10 nov 2025, 06:36 UTC

Winsten

Analysts Saw Hannover Re End-3Q Solvency II Ratio 261%

10 nov 2025, 06:36 UTC

Winsten

Hannover Re End-3Q Solvency II Ratio 259%

10 nov 2025, 06:35 UTC

Winsten

Hannover Re 3Q Return on Equity 22.5%

10 nov 2025, 06:35 UTC

Winsten

Hannover Re 3Q Return on Investment 1.9%

10 nov 2025, 06:35 UTC

Winsten

Hannover Re 3Q EBIT Margin 13.2%

10 nov 2025, 06:35 UTC

Winsten

Analysts Saw Hannover Re 3Q P&C Combined Ratio 87.0%

10 nov 2025, 06:35 UTC

Winsten

Hannover Re 3Q P&C Reinsurance Combined Ratio 80.8%

10 nov 2025, 06:34 UTC

Winsten

Analysts Saw Hannover Re 3Q EUR637M

10 nov 2025, 06:34 UTC

Winsten

Hannover Re 3Q Net Pft EUR651M

10 nov 2025, 06:34 UTC

Winsten

Analysts Saw Hannover Re 3Q EBIT EUR877M

10 nov 2025, 06:34 UTC

Winsten

Hannover Re 3Q EBIT EUR738M

10 nov 2025, 06:34 UTC

Winsten

Analysts Saw Hannover Re 3Q Investment Income EUR518M

10 nov 2025, 06:34 UTC

Winsten

Hannover Re 3Q Net Income from Investments EUR300M

10 nov 2025, 06:34 UTC

Winsten

Analysts Saw Hannover Re 3Q Net Reinsurance Service Result EUR801M

10 nov 2025, 06:34 UTC

Winsten

Hannover Re 3Q Net Reinsurance Service Result EUR969M

10 nov 2025, 06:33 UTC

Winsten

Analysts Saw Hannover Re 3Q Gross Reinsurance Rev EUR7.03B

10 nov 2025, 06:33 UTC

Winsten

Hannover Re 3Q Gross Reinsurance Rev EUR6.37B

10 nov 2025, 06:32 UTC

Winsten

Hannover Re Guides 2026 Net Income At Least EUR2.7B

10 nov 2025, 06:32 UTC

Winsten

Analysts See Hannover Re 2025 Net Income EUR2.57B

10 nov 2025, 06:32 UTC

Winsten

Hannover Re Had Seen 2025 Net Income Around EUR2.4B

10 nov 2025, 06:31 UTC

Winsten

Hannover Re Sees 2025 Net Income Around EUR2.6B

10 nov 2025, 06:31 UTC

Winsten

Hannover Re Raises 2025 Earnings View

Peer Vergelijking

Prijswijziging

Hannover Rueck SE Prognose

Koersdoel

By TipRanks

13.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 294.25 EUR  13.61%

Hoogste 350 EUR

Laagste 219 EUR

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Hannover Rueck SE - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

7

Buy

1

Hold

1

Sell

Technische score

By Trading Central

278.2 / 282.4Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Bullish Evidence

Sentiment

By Acuity

176 / 528 Rangschikking in Financiën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Hannover Rueck SE

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; catastrophe XL; credit, surety, and political risks; facultative; and marine and offshore energy businesses, as well as insurance-linked securities and structured reinsurance. It offers risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, the company offers group life, retirement, lifestyle, credit life, and Takaful reinsurance products. Further, the company provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and reinsurance and solvency II businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. Hannover Rück SE was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE operates as a subsidiary of Talanx AG.
help-icon Live chat